In this post we’re taking a look at what we learnt about immunometabolism at AACR20 and some of the early signals from a cancer new product development perspective.
Today’s focus is on an emerging new biotech company with potential…
The aim of this post is to give you a sense of the potential of immunometabolism to impact T cell fate, fitness, and function.
